Campbell & CO Investment Adviser LLC

Position in PRGO — PERRIGO Co plc

CIK 1353570 BALTIMORE, MD

Back to PRGO Full portfolio

Position in PRGO

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$2,079,090

+$1,809,001 QoQ

Shares Held

200,105

+931.3% QoQ

Ownership

0.144%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#73

of 334 holders

Holding Since

Mar 2022

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in PRGO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Campbell & CO Investment Adviser LLC holds $22,192,108 across 17 Drug Manufacturers - Specialty & Generic names. PRGO ranks #3 (9.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	13,309	$7,211,215
2	INDV	Indivior Pharmaceuticals, Inc.	69,871	$2,866,807
3	PRGO	PERRIGO Co plc This page	200,105	$2,079,090
4	AMLX	Amylyx Pharmaceuticals, Inc.	100,963	$1,813,295
5	ZTS	Zoetis Inc.	23,125	$1,661,762
6	HROW	Harrow, Inc.	36,286	$1,541,066
7	ELAN	Elanco Animal Health Inc	45,378	$1,116,752
8	PBH	Prestige Consumer Healthcare Inc.	19,175	$906,402

All Filings in PRGO

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,079,090	200,105	+931.3%	Shares	Sole	2026-08-03
2025-12-31	$270,089	19,403	-86.8%	Shares	Sole	2026-02-12
2025-03-31	$4,132,647	147,384	+450.7%	Shares	Sole	2025-05-14
2024-12-31	$688,025	26,761	+5.8%	Shares	Sole	2025-02-10
2024-09-30	$663,723	25,304	-26.1%	Shares	Sole	2024-11-12
2023-12-31	$1,102,293	34,254	-74.1%	Shares	Sole	2024-02-13
2023-09-30	$4,230,627	132,414	+1527.3%	Shares	Sole	2023-11-08
2022-09-30	$290,165	8,137	-81.6%	Shares	Sole	2022-11-14
2022-06-30	$1,795,871	44,266	+113.6%	Shares	Sole	2022-08-09
2022-03-31	$796,500	20,726	—	Shares	Sole	2022-05-09
No filing history on record for this holder in this stock.